New Results
A Systems-Level Framework for Drug Discovery Identifies Csf1R As A Novel Anti-Epileptic Drug Target
Prashant K Srivastava, Jonathan van Eyll, Patrice Godard, Manuela Mazzuferi, Benedicte Danis, Catherine Vandenplas, Patrik Foerch, Karine Leclercq, Georges Mairet-Coello, Frederic Vanclef, Kirill Shkura, Liisi Laaniste, Andree Delahaye-Duriez, Rafal M Kaminski, Enrico Petretto, Michael R Johnson
doi: https://doi.org/10.1101/140087
Prashant K Srivastava
1Division of Brain Sciences, Imperial College Faculty of Medicine, London, UK.
Jonathan van Eyll
2New Medicines R&D, UCB Pharma, Braine-l’Alleud, Belgium
Patrice Godard
3Clarivate Analytics (formerly the IP & Science business of Thomson Reuters), 5901 Priestly Dr., #200, Carlsbad, CA 92008, USA
Manuela Mazzuferi
2New Medicines R&D, UCB Pharma, Braine-l’Alleud, Belgium
Benedicte Danis
2New Medicines R&D, UCB Pharma, Braine-l’Alleud, Belgium
Catherine Vandenplas
2New Medicines R&D, UCB Pharma, Braine-l’Alleud, Belgium
Patrik Foerch
2New Medicines R&D, UCB Pharma, Braine-l’Alleud, Belgium
Karine Leclercq
2New Medicines R&D, UCB Pharma, Braine-l’Alleud, Belgium
Georges Mairet-Coello
2New Medicines R&D, UCB Pharma, Braine-l’Alleud, Belgium
Frederic Vanclef
2New Medicines R&D, UCB Pharma, Braine-l’Alleud, Belgium
Kirill Shkura
1Division of Brain Sciences, Imperial College Faculty of Medicine, London, UK.
Liisi Laaniste
1Division of Brain Sciences, Imperial College Faculty of Medicine, London, UK.
Andree Delahaye-Duriez
1Division of Brain Sciences, Imperial College Faculty of Medicine, London, UK.
4Université Paris 13, Sorbonne Paris Cité, UFR de Santé, Médecine et Biologie Humaine
5PROTECT, INSERM, Université Paris Diderot, Sorbonne Paris Cité
Rafal M Kaminski
2New Medicines R&D, UCB Pharma, Braine-l’Alleud, Belgium
Enrico Petretto
6Duke-NUS Medical School, Singapore
7MRC Clinical Sciences Centre, Imperial College Faculty of Medicine, London, UK
Michael R Johnson
1Division of Brain Sciences, Imperial College Faculty of Medicine, London, UK.
Article usage
Posted May 22, 2017.
A Systems-Level Framework for Drug Discovery Identifies Csf1R As A Novel Anti-Epileptic Drug Target
Prashant K Srivastava, Jonathan van Eyll, Patrice Godard, Manuela Mazzuferi, Benedicte Danis, Catherine Vandenplas, Patrik Foerch, Karine Leclercq, Georges Mairet-Coello, Frederic Vanclef, Kirill Shkura, Liisi Laaniste, Andree Delahaye-Duriez, Rafal M Kaminski, Enrico Petretto, Michael R Johnson
bioRxiv 140087; doi: https://doi.org/10.1101/140087
A Systems-Level Framework for Drug Discovery Identifies Csf1R As A Novel Anti-Epileptic Drug Target
Prashant K Srivastava, Jonathan van Eyll, Patrice Godard, Manuela Mazzuferi, Benedicte Danis, Catherine Vandenplas, Patrik Foerch, Karine Leclercq, Georges Mairet-Coello, Frederic Vanclef, Kirill Shkura, Liisi Laaniste, Andree Delahaye-Duriez, Rafal M Kaminski, Enrico Petretto, Michael R Johnson
bioRxiv 140087; doi: https://doi.org/10.1101/140087
Subject Area
Subject Areas
- Biochemistry (11718)
- Bioengineering (8724)
- Bioinformatics (29132)
- Biophysics (14936)
- Cancer Biology (12051)
- Cell Biology (17360)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14146)
- Epidemiology (2067)
- Evolutionary Biology (18269)
- Genetics (12223)
- Genomics (16768)
- Immunology (11844)
- Microbiology (28016)
- Molecular Biology (11560)
- Neuroscience (60822)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10401)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)